Results 121 to 130 of about 194,291 (245)

Prognostic benefit of immunosuppressive agents in primary Sjögren's syndrome patients with hypergammaglobulinemia. [PDF]

Front Immunol
Zhang L, Zou Y, Chen D, Zhang X, Jia Z, Zhang Q, Wang F, Feng X.   +7 more
europepmc   +1 more source

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. [PDF]

Infect Drug Resist, 2022
Seki M, Hashimoto K, Kondo N, Ohya Y, Kotajima F, Mitsutake K.   +5 more
europepmc   +1 more source

Supramolecular Assembly of Stepped‐Persistent ROS Nanogenerator for Sustained Tumor Immunotherapy

Advanced Science, EarlyView.
ROS catalytic systems often fail to achieve both effective tumor elimination and persistent immune activation due to their monotonous ROS production profiles. A stepped‐persistent ROS nanogenerator was developed by supramolecularly assembling multiple ROS generation modules within a nanofiber structure to simultaneously extend ROS generation duration ...
Zhenqiang Wang, Ming Qin, Wenjing Lai, Shiwen Chen, Fengling Wang, Dandan Xie, Maohua Chen, Changpeng Hu, Kui Wang, Rong Zhang, Guobing Li   +10 more
wiley   +1 more source

Immunosuppressive agents in diabetes treatment: Hope or despair? [PDF]

World J Diabetes
Li L, Yang X, Ren JS, Huang MZ, Zhao QW.
europepmc   +1 more source

The relationship between cumulative dose of immunosuppressive agents and COVID-19-associated mucormycosis: A multicenter cross-sectional study. [PDF]

Health Sci Rep, 2022
Rastkar M, SeyedAlinaghi S, Asanjarani B, Siri G, Abdollahi H, Ghadami L, Hasibi M, Khodashahi R, Bagheri A, Asadollahi-Amin A.   +9 more
europepmc   +1 more source

Targeting PLD3 Reverses the Immunosuppressive Niche by Reprogramming Tumor‐Associated Macrophages and Potentiates Antitumor Immunity

Advanced Science, EarlyView.
PLD3 activates the lysosomal‐AKT‐NF‐κB axis to drive cellular senescence in macrophages, establishing an immunosuppressive TME by limiting the infiltration of cytotoxic T, NK, and NKT cells, which confers resistance to anti‐PD‐1 therapy. Abrine inhibits PLD3 expression, restoring antitumor immunity and synergizing with anti‐PD‐1 treatment.
Xingtu Qin, Qiong Li, Xuemei Xu, Yuhan Wu, Yin Zhu, Jieqiong Wu, Yuan Fang, Qiubei Chen, Shuyang Wang, Jiang Yu, Yaping Ye, Hongli Jiao   +11 more
wiley   +1 more source

A case of localized abdominal aortic dissection secondary to retroperitoneal fibrosis cured only with glucocorticoids and immunosuppressive agents. [PDF]

Quant Imaging Med Surg, 2023
Zhang C, Liu Y, Ma N.
europepmc   +1 more source

SIRT6‐Mediated Deacetylation of ATF3 Promotes Silica‐Induced Lung Fibrosis by Enhancing its Nuclear Import via Binding to Importin α

Advanced Science, EarlyView.
SIRT6‐mediated ATF3 acetylation drives MGARP transcription and mitochondrial dysfunction in macrophages, promoting macrophage senescence and pulmonary fibrosis. Mechanistically, HSP70/Importin α competitively binds to ATF3, modulating its nuclear translocation.
Demin Cheng, Wenxia Bu, Fengxu Wang, Yueyuan Jin, Rongzhu Liu, Rui Zhao, Xuehai Wang, Mengna Jiang, Jinping Shen, Xinhang Cheng, Zuming Chen, Li Zhu, Jinlong Li, Zhenzhong Ge, Shichen Miao, Haotian Xu, Xiaoyu Zhou, Dongming Wang, Xinyuan Zhao   +18 more
wiley   +1 more source

Efficacy of Rituximab as Adjunctive Therapy to Immunosuppressive Agents in Adult Primary Focal Segmental Glomerulosclerosis. [PDF]

Kidney Int Rep
Mohamed ON, Mohamed MI, Mohammed Elsaghir SM, Abdelrazek S, Azzam A, Senosy Mohamed TM, Mohammed HMH, Yousef R, Abd Rabou AA, Abdelazeem Elgarhy RY, Mohamed Mahdy AK, Abdelsamie MA, Sayed MM, Fathi E, Mohammed Toni ND, Saleh RK, Fathy B.   +16 more
europepmc   +1 more source

Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation. [PDF]

Saudi Pharm J, 2023
Mehmood Y, Shahid H, Abbas M, Farooq U, Farooq U, Ali S, Kazi M.   +6 more
europepmc   +1 more source